CIBC Private Wealth Group LLC Trims Holdings in HealthEquity, Inc. $HQY

CIBC Private Wealth Group LLC decreased its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 81.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 213,406 shares of the company’s stock after selling 913,648 shares during the quarter. CIBC Private Wealth Group LLC owned 0.25% of HealthEquity worth $20,224,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. Simplify Asset Management Inc. acquired a new stake in HealthEquity during the third quarter worth about $1,498,000. 12th Street Asset Management Company LLC lifted its holdings in HealthEquity by 114.4% in the third quarter. 12th Street Asset Management Company LLC now owns 272,068 shares of the company’s stock valued at $25,784,000 after acquiring an additional 145,151 shares during the period. Oppenheimer Asset Management Inc. lifted its holdings in HealthEquity by 45.5% in the third quarter. Oppenheimer Asset Management Inc. now owns 155,543 shares of the company’s stock valued at $14,741,000 after acquiring an additional 48,621 shares during the period. Bessemer Group Inc. boosted its position in HealthEquity by 21.3% in the 3rd quarter. Bessemer Group Inc. now owns 349,342 shares of the company’s stock worth $33,108,000 after purchasing an additional 61,317 shares in the last quarter. Finally, GDS Wealth Management boosted its position in HealthEquity by 15.7% in the 3rd quarter. GDS Wealth Management now owns 100,969 shares of the company’s stock worth $9,569,000 after purchasing an additional 13,682 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity News Roundup

Here are the key news stories impacting HealthEquity this week:

• Positive Sentiment: Deutsche Bank raised its price target to $128 and kept a “buy” rating — the new target implies ~57.8% upside from the current price, signaling strong analyst conviction. Deutsche Bank price target raise
• Positive Sentiment: Q4 2026 results and call highlighted record HSA growth, revenue and EPS beats (quarterly revenue and EPS modestly ahead of consensus), supporting continued top-line momentum and cash economics. HQY Q4 2026 Earnings Call Highlights
• Positive Sentiment: Seeking Alpha published a rating upgrade citing improved cash economics, which reinforces buy-side theses around margin expansion and free cash flow improvement. Seeking Alpha upgrade
• Positive Sentiment: Press roundup / analyst commentary piece flagged HealthEquity among bullish healthcare names, adding to positive market narrative. Globe & Mail analyst roundup
• Neutral Sentiment: Full Q4 earnings call transcripts were posted across outlets (MSN, Seeking Alpha, Yahoo) — useful for digging into management commentary on enrollment, revenue cadence and margin drivers but not new information beyond the released results. MSN earnings transcript Seeking Alpha earnings transcript
• Negative Sentiment: Barrington Research trimmed its price target from $125 to $110 (still “outperform”), reducing upside assumptions to ~35.6% and signaling slightly less bullishness from one coverage shop. Barrington price target update
• Negative Sentiment: JPMorgan lowered its target from $129 to $123 but maintained an “overweight” rating, trimming some upside expectations while staying constructive (~51.6% implied upside). JPMorgan price target update
• Negative Sentiment: RBC cut its target from $110 to $100 (still “outperform”), tightening the analyst target band and signaling a more cautious near-term view. RBC price target update

Analyst Ratings Changes

HQY has been the topic of a number of analyst reports. Barrington Research dropped their price objective on shares of HealthEquity from $125.00 to $110.00 and set an “outperform” rating on the stock in a research note on Wednesday. Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a report on Thursday, January 22nd. Deutsche Bank Aktiengesellschaft raised their price target on shares of HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a research report on Thursday. BTIG Research cut their price objective on shares of HealthEquity from $130.00 to $110.00 and set a “buy” rating for the company in a report on Tuesday, February 17th. Finally, Citizens Jmp set a $122.00 price objective on shares of HealthEquity in a research report on Thursday, December 4th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $110.36.

HealthEquity Stock Up 2.0%

Shares of NASDAQ HQY opened at $81.13 on Friday. The stock has a market cap of $6.85 billion, a PE ratio of 32.98, a P/E/G ratio of 0.99 and a beta of 0.26. The company has a current ratio of 3.27, a quick ratio of 4.13 and a debt-to-equity ratio of 0.45. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $116.65. The company has a 50-day moving average of $80.59 and a 200 day moving average of $90.13.

HealthEquity (NASDAQ:HQY) last released its earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.05. The business had revenue of $334.59 million for the quarter, compared to analyst estimates of $332.48 million. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. The firm’s revenue for the quarter was up 7.3% compared to the same quarter last year. As a group, sell-side analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.